Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins

Cancer Research

Volumn 60, Issue 12, 2000, Pages 3117-3122

  Abe, Nobutsugu ^a   Watanabe, Takashi ^a   Masaki, Tadahiko ^a   Mori, Toshiyuki ^a   Sugiyama, Masanori ^a   Uchimura, Hidemasa ^a   Fujioka, Yasunori ^a   Chiappetta, Gennaro ^b   Fusco, Alfredo ^c   Atomi, Yutaka ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP PROTEIN;

ARTICLE; CANCER DIAGNOSIS; CORRELATION FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS CARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

CARCINOMA; CYSTADENOMA, SEROUS; HIGH MOBILITY GROUP PROTEINS; HMGA1A PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PANCREATITIS; PAPILLOMA; PHENOTYPE; TRANSCRIPTION FACTORS;

EID: 0034088188     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bustin, M., and Reeves, R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. In: W. E. Cohn and K. Moldave (eds.), Progress in Nucleic Acid Research and Molecular Biology, Vol. 54, pp. 35-100. San Diego, CA: Academic Press, 1996.
2. Johnson, K. R., Lehn, D. A., Elton, T. S., Barr, P. J., and Reeves, R. Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMGI(Y). J. Biol. Chem., 263: 18338-18342, 1988.
3. Manfioletti, G., Giancotti, V., Bandiera, A., Buratti, E., Sautiewre, P., Cary, P., Crane-Robinson, C., Coles, B., and Goodwin, G. H. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res., 19: 6793-6797, 1991.
4. Manfioletti, G., Rustighi, A., Mantovani, F., Goodwin, G. H., and Giancotti, V. Isolation and characterization of the gene coding for murine high-mobility-group protein HMGI-C. Gene (Amst.), 167: 249-253, 1995,
5. Reeves, R., and Nissen, M. S. The AT DNA binding domain of mammalian high mobility group 1 chromosomal proteins: a novel peptide motif for recognizing DNA structure. J. Biol. Chem., 265: 8576-8582, 1990.
6. Thanos, D., and Maniatis, T. The high mobility group protein HMGI(Y) is required for NF-KB dependent virus induction of the human 1FN-β gene. Cell. 71: 777-789, 1992.
7. Du, W., Thanos, D., and Maniatis, T. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell, 74: 887-898, 1993.
8. John, S., Reeves, R. B., Lin, J. X., Child, R., Leiden, J. M., Thompson, C. B., Leonard, W. J. Regulation of cell-type specific interleukin-2 receptor α-chain gene expression: potential role of physical interactions between Elf-1, HMGI(Y), and NF-KB family proteins. Mol. Cell. Biol., 15: 1786-1796, 1995.
9. Thanos, D., and Maniatis, T. Virus induction of human IFNβ gene expression requires the assembly of an enhancesome. Cell, 83: 1091-1100, 1995.
10. Falvo, J. V., Thanos, D., and Maniatis, T. Reversal of intrinsic DNA bends in the IFNβ gene by transcription factors and the architectural protein HMGI(Y). Cell, 83: 1101-1111, 1995,
11. Zhou, X., Benson, K. F., Ashar, H. R., and Chada, K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature (Lond.) 376: 771-774, 1995.
12. Chiappetta, G., Avantaggiato, V., Visconti, R., Fedele, M., Battista, S., Trapasso, F., Merciai, B. M., Fidanza, V., Giancotti, V., Santoro, M., Simeone, A., and Fusco, A. High level expression of the HMGI(Y) gene during embryonic development. Oncogene, 13: 2439-2446 1996.
13. Tkachenko, A., Ashar, H. R., Meloni, A. M., Sandberg, A. A., and Chada, K. K. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res., 57: 2276-2280, 1997.
14. Chiappetta, G., Bandiera, A., Berlingieri, M. T., Visconti, R., Manfioletti, G., Battista, S., Martinez-Tello, F. J., Santoro, M., Giancotti, V., and Fusco, A. The expression of the high mobility group HMGI(Y) proteins correlates with the malignant phenotype of human thyroid neoplasm. Oncogene, 10: 1307-1314, 1995.
15. Tamimi, Y., van der Poel, H. G., Karthaus, H. F. M., Debruyne, F. M. J., and Schalken, J. A. A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization. Br. J. Cancer, 74: 573-578, 1996.
16. Bandiera, A., Bonifacio, D., Manfioletti, G., Mantovani, F., Rustighi, A., Zanconati, F., Fusco, A., Bonito, L. D., and Giancotti, V. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res., 58: 426-431, 1998.
17. Fedele, M., Bandiera, A., Chiappetta, G., Battista, S., Viglietto, G., Visconti, R., Manfioletti, G., Casamassimi, A., Santoro, M., Giancotti, V., and Fusco, A. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res., 56: 1896-1901, 1996.
18. Abe, N., Watanabe T., Sugiyama, M., Uchimura, H., Chiapetta, G., Fusco, A., and Atomi, Y. Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker. Cancer Res., 59: 1169-1174, 1999.
19. Berlingieri, M. T., Manfioletti, G., Santoro, M., Bandiera, A., Visconti, R., Giancotti, V., and Fusco, A. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol., 15: 1545-1553, 1995.
20. Mizumoto, K., Tsutsumi, M., Denda, A., and Konishi, Y. Rapid production of pancreatic carcinoma by initiation with N-nitro-bis(2-oxopropyl)amine and repeated augmentation pressure in hamsters. J. Natl. Cancer Inst., 80: 1564-1567, 1988.
21. Yi-Mings, S., Cheng-His, S., Shy-Haw, T., and Wing-Yiu, L. Mucin-producing neoplasms of the pancreas. Ann. Surg., 223: 141-146, 1996.
22. Perez-Ordonez, B., Naseem, A., Lieberman, P. H., and Klimsta, D. S. Solid serous adenoma of the pancreas. Am. J. Surg. Pathol., 20: 1401-1405, 1996.
23. Mao, C., Guvendi, M., Domenico, D. R., Kim, K., Thomford, N. R., and Howard, J. M. Papillary cystic and solid tumors of the pancreas: a pancreatic embryonic tumor? Studies of three cases and cumulative review of the world's literature. Surgery (St. Louis), 118: 821-828, 1995.
24. Yamaguchi, K., Chijiiwa, K., Saiki, S., Nakatsuka, A., and Tanaka, M. "Mass-forming" pancreatitis masquerades as pancreatic carcinoma. Int. J. Pathol., 20: 27-35, 1996.
25. Sugiyama, M., and Atomi, Y. Intraductal papillary mucinous tumors of the pancreas. Imaging studies and treatment strategies. Ann. Surg. 225: 685-691, 1998.
26. Sharma, M. P., Gregg, J. A., Loewenstein, M. S., McCabe, R. P., and Zamcheck, N. Carcino-embryonic antigen activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis. Cancer (Phila.), 38: 2457-2461, 1976.
27. Wakabayashi, T., Sawabu, N., Takemori, Y., Satomura, Y., Kidani, H., Ohta, H., Watanabe, H., Yamakawa, O., Takahashi, H., Watanabe, K., and Konishi, F. Diagnostic significance of cancer-associated carbohydrate antigen (CA19-9) concentrations in pancreatic juice: analysis in pure pancreatic juice collected by endoscopic aspiration and immunohistochemical study in chronic pancreatitis. Pancreas, 8: 151-159, 1993.
28. Watanabe, H., Sawabu, N., Songur, Y., Yamaguchi, Y., Yamakawa, O., Satomura, Y., Ohta, H., Motoo, Y., Okai, T., and Wakabayashi, T. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis. Pancreas, 12: 18-24, 1996.
29. Tada, M., Ohashi, M., Shiratori, Y., Okudaira, T., Komatsu, Y., Kawabe, T., Yoshida, H., Machinami, R., Kishi, K., and Omata, M. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology, 110: 227-231, 1996.